Prescribe infliximab by brand name, says ARA


The ARA has advised its members to prescribe infliximab by brand name and consider ticking the ‘brand substitution not permitted’ box on prescriptions. In a letter to its members President Dr Mona Marabani said that while the ARA supported moves to ensure value for money for the PBS it remained concerned about the decision to ...


Already a member? Login to keep reading


OR
© 2017 the limbic